32
Growth Score in past quarter
pts
Heat Score 32 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1336040
Innovative biopharmaceuticals for neurodegenerative diseases
About the Company
Targeting Neurodegeneration with Engineered Erythropoietin.
BioSynaptica is a biotech startup pioneering the development of innovative biotherapeutics derived from human erythropoietin (hEPO) for the treatment of neurodegenerative disorders, with a focus on retinal diseases.